Bank of New York Mellon Corp Buys 68,598 Shares of Avantor, Inc. (NYSE:AVTR)

Bank of New York Mellon Corp grew its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,830,719 shares of the company's stock after purchasing an additional 68,598 shares during the quarter. Bank of New York Mellon Corp owned about 0.71% of Avantor worth $101,783,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its holdings in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after buying an additional 625 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after acquiring an additional 835 shares during the period. Global Retirement Partners LLC boosted its position in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock valued at $52,000 after acquiring an additional 1,067 shares during the period. UMB Bank n.a. grew its stake in shares of Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after acquiring an additional 1,074 shares during the last quarter. Finally, CKW Financial Group increased its position in Avantor by 116.7% during the fourth quarter. CKW Financial Group now owns 5,200 shares of the company's stock worth $110,000 after acquiring an additional 2,800 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Remove Ads

Insider Buying and Selling

In related news, EVP James Bramwell sold 3,758 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares of the company's stock, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The disclosure for this sale can be found here. 1.30% of the stock is owned by corporate insiders.

Avantor Price Performance

Shares of NYSE:AVTR traded up $0.25 on Wednesday, hitting $15.75. The stock had a trading volume of 7,605,768 shares, compared to its average volume of 5,941,737. The firm's 50 day moving average price is $20.18 and its 200-day moving average price is $22.47. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a twelve month low of $15.37 and a twelve month high of $28.00. The company has a market capitalization of $10.73 billion, a price-to-earnings ratio of 15.15, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period last year, the firm earned $0.22 EPS. On average, equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on AVTR. Morgan Stanley decreased their price target on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Monday, February 10th. Stifel Nicolaus lowered their price target on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Royal Bank of Canada reduced their price objective on Avantor from $33.00 to $31.00 and set an "outperform" rating for the company in a research report on Monday, February 10th. UBS Group reissued a "neutral" rating and set a $25.00 price objective (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Citigroup cut their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, Avantor presently has an average rating of "Moderate Buy" and an average target price of $25.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.